Trending

gastroenterology

Takeda’s Entyvio outperforms AbbVie’s Humira in GI trial

Takeda’s Entyvio outperforms AbbVie’s Humira in GI trial

Takeda has announced results from its gastro drug Entyvio, showing that it largely outperformed the industry standard –

X

Takeda’s Entyvio outperforms AbbVie’s Humira in GI trial

https://pharmaphorum.com/news/takedas-entyvio-outperforms-abbvies-humira-in-gi-trial/

Cosmo’s diarrhoea drug approved, threatening Salix’ cash cow

Cosmo’s diarrhoea drug approved, threatening Salix’ cash cow

Ireland’s Cosmo Pharma claimed FDA approval for its traveller’s diarrhoea drug Aemcolo, which some analysts say could be

X

Cosmo’s diarrhoea drug approved, threatening Salix’ cash cow

https://pharmaphorum.com/news/cosmos-diarrhoea-drug-approved-threatening-salix-cash-cow/

Blueprint eyes quick filing for GIST drug avapritinib

Blueprint eyes quick filing for GIST drug avapritinib

Blueprint Medicines has new data for its lead cancer drug avapritinib in gastrointestinal stromal tumours (GIST) that set

X

Blueprint eyes quick filing for GIST drug avapritinib

https://pharmaphorum.com/news/blueprint-eyes-quick-filing-for-gist-drug-avapritinib/

Takeda to buy stem cell specialists TiGenix for $626m

Takeda to buy stem cell specialists TiGenix for $626m

Decision follows EU regulators’ decision to back Crohn’s stem cell therapy

X

Takeda to buy stem cell specialists TiGenix for $626m

https://pharmaphorum.com/news/takeda-buy-gastro-biotech-tigenix-463m/

First ever ‘off the shelf’ stem cell therapy nears European approval

First ever ‘off the shelf’ stem cell therapy nears European approval

Alofisel recommended for complex perianal fistulas in Crohn’s disease

X

First ever ‘off the shelf’ stem cell therapy nears European approval

https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/

Acacia ready to file its anti-vomiting treatment

Acacia ready to file its anti-vomiting treatment

Potential launch in 2018 if FDA approves Baremsis.

X

Acacia ready to file its anti-vomiting treatment

https://pharmaphorum.com/news/acacia-pharma/

Valeant could sell gastro drug unit to Takeda

Valeant could sell gastro drug unit to Takeda

Valeant may sell Salix and other units to pay off debts.

X

Valeant could sell gastro drug unit to Takeda

https://pharmaphorum.com/news/valeant-could-sell-gastro-drug-unit-to-takeda/

Allergan snaps up Motus for $200 million

Allergan snaps up Motus for $200 million

Big pharma exercises option following gastro success.

X

Allergan snaps up Motus for $200 million

https://pharmaphorum.com/news/allergan-snaps-motus-200-million/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com